Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor
about
Calcium phosphate nanoparticles-based systems for siRNA deliveryCurrent and Future Theranostic Applications of the Lipid-Calcium-Phosphate Nanoparticle Platform.Strategies on the nuclear-targeted delivery of genessiRNA delivery to the lung: what's new?Exploring the tumor microenvironment with nanoparticlesLipid-based vectors for siRNA deliveryCombinational delivery of c-myc siRNA and nucleoside analogs in a single, synthetic nanocarrier for targeted cancer therapy.How does the cell overcome LCP nanoparticle-induced calcium toxicity?A dosimetric model for the heterogeneous delivery of radioactive nanoparticles In vivo: a feasibility studyLipoprotein-biomimetic nanostructure enables efficient targeting delivery of siRNA to Ras-activated glioblastoma cells via macropinocytosis.Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model.siRNA Delivery Strategies: A Comprehensive Review of Recent Developments.Co-delivery of cisplatin and rapamycin for enhanced anticancer therapy through synergistic effects and microenvironment modulation.Maximizing the Supported Bilayer Phenomenon: Liposomes Comprised Exclusively of PEGylated Phospholipids for Enhanced Systemic and Lymphatic Delivery.Recent In Vivo Evidences of Particle-Based Delivery of Small-Interfering RNA (siRNA) into Solid TumorsNanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer.Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.Turning an antiviral into an anticancer drug: nanoparticle delivery of acyclovir monophosphate.Development of small RNA delivery systems for lung cancer therapy.A Biocompatible Reconstituted High-Density Lipoprotein Nano-System as a Probe for Lung Cancer Detection.Biocompatible and colloidally stabilized mPEG-PE/calcium phosphate hybrid nanoparticles loaded with siRNAs targeting tumors.Nanoparticle delivery of CDDO-Me remodels the tumor microenvironment and enhances vaccine therapy for melanoma.Multifunctional Nanoparticles Facilitate Molecular Targeting and miRNA Delivery to Inhibit Atherosclerosis in ApoE(-/-) Mice.A radio-theranostic nanoparticle with high specific drug loading for cancer therapy and imagingNanoparticle delivery of pooled siRNA for effective treatment of non-small cell lung cancerTargeted delivery of EV peptide to tumor cell cytoplasm using lipid coated calcium carbonate nanoparticles.Effect of surface properties on liposomal siRNA delivery.Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: Turning a bone antiresorptive agent into an anticancer therapeutic.Nanoparticle Delivered VEGF-A siRNA Enhances Photodynamic Therapy for Head and Neck Cancer TreatmentSystemic delivery of gemcitabine triphosphate via LCP nanoparticles for NSCLC and pancreatic cancer therapyReductively Responsive Hydrogel Nanoparticles with Uniform Size, Shape, and Tunable Composition for Systemic siRNA Delivery in Vivo.Preparation of optimized lipid-coated calcium phosphate nanoparticles for enhanced in vitro gene delivery to breast cancer cellsProgress and perspective of inorganic nanoparticle-based siRNA delivery systemsA highly efficient synthetic vector: nonhydrodynamic delivery of DNA to hepatocyte nuclei in vivo.Codelivery of VEGF siRNA and gemcitabine monophosphate in a single nanoparticle formulation for effective treatment of NSCLC.Nanoparticle delivery of HIF1α siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer.Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles.Unmodified drug used as a material to construct nanoparticles: delivery of cisplatin for enhanced anti-cancer therapyNanoparticles containing insoluble drug for cancer therapy.Lipid-calcium phosphate nanoparticles for delivery to the lymphatic system and SPECT/CT imaging of lymph node metastases.
P2860
Q26744039-37A9EB65-13E4-4CD0-83B2-9539DCFA09FDQ26746186-A4216653-395B-4FEE-95A8-2A01E5CD0495Q26852376-EFD9FA0E-41A4-495E-AEA1-46A09D71D720Q27022043-B391A9C9-2FBB-47E5-88F2-69371ADA3FC9Q28082374-700CDA5F-4FB4-45C8-AD3F-7C2453240C27Q28828356-4EFD17D0-051F-4371-9231-A9D5F5767422Q30572043-54676103-C27A-4A91-8441-D3B3C03A3F56Q30573647-91763CB8-D84A-4694-AFF5-FD6B950F211FQ30842183-4AAEE385-3DDA-41DC-82D9-88190ED9ACD7Q30851435-A2B49021-388C-435C-B06C-20F70074A51EQ33564844-22DBDB0D-AE1A-4ABB-9830-F3B41A37A83CQ33611947-E9ACC5E8-52F2-49CE-93F8-6C3EAD4EC84DQ33716011-10CDB8DC-3D2D-491C-840B-A977795F3144Q33908258-A8586138-F43B-46DA-9779-439A20D00D89Q34165321-7B2F5165-22CF-4830-BC07-A9285B4D1AD1Q34479313-22D6F04B-CAFB-4020-8E75-DE9AEB54AC24Q34622662-02234AF8-76E4-4F86-A8F4-F66860C6EA88Q34781094-B4A15E32-9806-4BCC-8443-226F682213E3Q35380932-820E346C-624C-47D5-A12D-A46B93E9D044Q35771918-5C748D52-0FCC-4857-B934-8749F87E17D3Q35857347-4F60CF33-727E-44A2-A885-D518CED4DDB6Q35999941-986AD306-89A5-446D-82A5-7E3EE7C27412Q36089057-DD1E01FF-0E8E-4822-8B4A-7165F87DFD36Q36268337-1BE4DDCF-29CD-432E-BD8E-AAFBD8238952Q36356958-B576C9BE-3DEC-43D0-A549-0BD33304D9AEQ36395067-E85781E8-CA02-47D2-A8B8-A8EFC6EFDA66Q36421379-5AB8BE0E-E2B8-45F8-91B5-EBD23B0589FEQ36505631-736D5506-8FE0-44B2-A5B4-094FB166B0A6Q36582823-2D054D11-672F-40D6-A034-46EC2EDBA72EQ36693506-D9DED28F-1CA7-4F5E-9368-56C03C187ADAQ36821612-A82E66D1-1ED5-4B2A-8D00-711D2624AE80Q36907352-6A2D85FD-3618-49A1-A09A-83CDFBFBAD8AQ37021426-C2E801DC-9796-411C-B733-33C083793BF3Q37031613-861A05DF-CA07-4DCD-B1BF-1377EC8CA2EDQ37073105-DFEA7BD7-DC05-487C-90ED-EABB4D7A17E2Q37229892-96ECF27A-3F2C-42E4-A4AC-27904896FBC9Q37588032-01BCB524-571F-41C4-85A6-0407377B48F7Q37625480-D5F2037B-2931-44B8-B192-5225F62342B5Q37693046-BD0FE8E6-021B-48EA-9F9A-6CC5943B5A3AQ37731821-874FCEFB-C43B-45BB-A465-10FF9C469E85
P2860
Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Calcium phosphate nanoparticle ...... or siRNA delivery to the tumor
@ast
Calcium phosphate nanoparticle ...... or siRNA delivery to the tumor
@en
type
label
Calcium phosphate nanoparticle ...... or siRNA delivery to the tumor
@ast
Calcium phosphate nanoparticle ...... or siRNA delivery to the tumor
@en
prefLabel
Calcium phosphate nanoparticle ...... or siRNA delivery to the tumor
@ast
Calcium phosphate nanoparticle ...... or siRNA delivery to the tumor
@en
P2093
P2860
P1476
Calcium phosphate nanoparticle ...... or siRNA delivery to the tumor
@en
P2093
P2860
P304
P356
10.1016/J.JCONREL.2011.10.020
P407
P577
2011-10-26T00:00:00Z